Skip to main content
Premium Trial:

Request an Annual Quote

Peakdale Molecular s Peakexplorer GPCR Library, GE Healthcare s CodeLink ADME Rat 16-Assay, and BD Biosciences BD Taq Full DNA Polymerase

Premium

Peakdale Molecular this week launched a fourth Peakexplorer GPCR library. The newest edition has more than 1,100 compounds intended for screening against G-protein coupled receptors, including a “novel” chemotype designed to “take advantage” of the manufacturer’s expertise, the company said.


The CodeLink ADME Rat 16-Assay joined GE Healthcare’s gene-expression microarray ranks last week, according to a company statement. The array has a multi-assay chamber allowing the parallel processing of a maximum of 16 samples on each slide, with 1,200 functionally validated oligo ADME probes per array, GE said.


BD Biosciences launched its BD Taq Full DNA polymerase last week, the company said. The enzyme is intended for general PCR, and BD boasts the “highest” yields from “any” DNA template, along with “high efficiency and sensitivity,” and it can be purchased with a hot-start antibody, BD said.

 

Filed under

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.